← All stocks

GSK vs SNY

GSK plc American Depositary Shares (Each representing two Ordinary Shares) vs Sanofi ADS. Side-by-side ACCE scores, valuation, profitability, and growth.

ACCE scores
GSK
SNY
Composite score
Out of 100
63
59
Growth
28
40
Value
81
80
Quality
88
75
Momentum
54
40
Valuation
GSK
SNY
Price
51.08
42.50
Market cap
100.58B
101.79B
Trailing P/E
15.94
22.96
Forward P/E
9.67
8.58
EV / EBITDA
9.34
12.84
Dividend yield
3.6%
9.6%
Profitability
GSK
SNY
ROE
33.4%
5.7%
Net margin
14.5%
8.1%
Debt / equity
1.03
0.26
Free cash flow
5.82B
10.14B
Growth
GSK
SNY
Revenue growth (YoY)
5.3%
14.6%
Earnings growth (YoY)
-69.5%
-91.2%
Analyst target
59.33
53.72
See full analysis